{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:33:48Z","timestamp":1786991628247,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jchromb.2019.05.038","type":"journal-article","created":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T11:25:55Z","timestamp":1559301955000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Innovative HPTLC method for simultaneous determination of ternary mixture of certain DMARDs in real samples of rheumatoid arthritis patients: an application of quality by design approach"],"prefix":"10.1016","volume":"1124","author":[{"given":"Wesam M.","family":"El-Koussi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha N.","family":"Atia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal A.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Hammam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2019.05.038_bb0005","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0140-6736(94)91161-4","article-title":"Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients","volume":"343","author":"Trialists","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0010","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1002\/art.21405","article-title":"Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial","volume":"52","author":"Goekoop-Ruiterman","year":"2005","journal-title":"Arthritis Rheumatol."},{"issue":"845496","key":"10.1016\/j.jchromb.2019.05.038_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2011\/845496","article-title":"Cost effectiveness analysis of disease-modifying antirheumatic drugs in rheumatoid arthritis. A systematic review literature","volume":"2011","author":"Benucci","year":"2011","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133858","article-title":"Prevalence of arthritis in Africa: a systematic review and meta-analysis","volume":"10","author":"Usenbo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0025","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1002\/art.21293","article-title":"Superior efficacy of combination therapy for rheumatoid arthritis: fact or fiction?","volume":"52","author":"Smolen","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0030","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1124\/pr.57.2.3","article-title":"Low-dose methotrexate: a mainstay in the treatment of rheumatoid arthritis","volume":"57","author":"Cronstein","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4137\/CMAMD.S5558","article-title":"Pharmacotherapy options in rheumatoid arthritis","volume":"6","author":"Kumar","year":"2013","journal-title":"Clin. Med. Insights Arthritis Musculoskelet. Disord."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0040","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/rheumatology\/36.7.799","article-title":"Antimalarial drugs in the treatment of rheumatological diseases","volume":"36","author":"Rynes","year":"1997","journal-title":"Rheumatology"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0045","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/art.10228","article-title":"Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial","volume":"46","author":"O\u2019Dell","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0050","first-page":"95","article-title":"Spectrofluorimetric methotrexate assay in human plasma","volume":"58","author":"B\u0103rc\u0103","year":"2010","journal-title":"Farmacia"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchromb.2013.07.026","article-title":"A validated LC\u2013MS\/MS method for rapid determination of methotrexate in human saliva and its application to an excretion evaluation study","volume":"937","author":"Rodin","year":"2013","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jpha.2015.12.001","article-title":"Optimized high performance liquid chromatography\u2013ultraviolet detection method using core-shell particles for the therapeutic monitoring of methotrexate","volume":"6","author":"Montemurro","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0065","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.snb.2016.08.064","article-title":"Glassy carbon electrode modified with 3D graphene\u2013carbon nanotube network for sensitive electrochemical determination of methotrexate","volume":"239","author":"Asadian","year":"2017","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0070","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jpba.2018.06.011","article-title":"Simultaneous determination of plasma methotrexate and 7-hydroxy methotrexate by UHPLC\u2013MS\/MS in patients receiving high-dose methotrexate therapy","volume":"158","author":"Mei","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0075","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0731-7085(95)01304-4","article-title":"Quantitative determination of sulfasalazine by near-infrared spectroscopy and multivariate analysis in reflectance mode with a fibre-optic probe","volume":"13","author":"Jacobsson","year":"1995","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0080","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.aca.2006.10.028","article-title":"Immunochemical method for sulfasalazine determination in human plasma","volume":"583","author":"Pastor-Navarro","year":"2007","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0085","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.snb.2012.04.031","article-title":"Electroanalytical determination of sulfasalazine in pharmaceutical and biological samples using molecularly imprinted polymer modified carbon paste electrode","volume":"168","author":"Sadeghi","year":"2012","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jelechem.2014.05.034","article-title":"Sensitive detection of sulfasalazine at screen printed carbon electrode modified with functionalized multiwalled carbon nanotubes","volume":"727","author":"Sadeghi","year":"2014","journal-title":"J. Electroanal. Chem."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0095","first-page":"1","article-title":"Smartphone-based colorimetric determination of sulfadiazine and sulfasalazine in pharmaceutical and veterinary formulations","author":"Ait Errayess","year":"2018","journal-title":"Instrum. Sci. Technol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0378-4347(94)00584-R","article-title":"Simple and specific reversed-phase liquid chromatographic method with diode-array detection for simultaneous determination of serum hydroxychloroquine, chloroquine and some corticosteroids","volume":"666","author":"Volin","year":"1995","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/elps.200600420","article-title":"Stereoselective determination of hydroxychloroquine and its metabolites in human urine by liquid-phase microextraction and CE","volume":"28","author":"de Oliveira","year":"2007","journal-title":"Electrophoresis"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cca.2013.02.018","article-title":"A rapid and reliable method for the quantitation of hydroxychloroquine in serum using turbulent flow liquid chromatography-tandem mass spectrometry","volume":"421","author":"F\u00fcz\u00e9ry","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0115","doi-asserted-by":"crossref","first-page":"e4258","DOI":"10.1002\/bmc.4258","article-title":"Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood","volume":"32","author":"Bruno","year":"2018","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0120","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1080\/01483919008049002","article-title":"A simple reversed-phase partition thin-layer chromatographic method for rapid identification and quantitation of methotrexate in presence of its disintegration products","volume":"13","author":"Datta","year":"1990","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0125","first-page":"551","article-title":"Densitometric determination of impurities in pharmaceuticals part V. Determination of folic acid and 2,4-diaminopteridine-6-carboxylic acid in methotrexate","volume":"45","author":"Krzek","year":"2000","journal-title":"Chem. Anal."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0130","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1556\/AChrom.27.2015.4.4","article-title":"TLC\u2014densitometric determination of sulfasalazine and its possible impurities in pharmaceutical preparations","volume":"27","author":"Kwiecie\u0144","year":"2015","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0378-5173(88)90276-1","article-title":"Photochemical stability of antimalarial. I. Hydroxychloroquine","volume":"43","author":"T\u00f8nnesen","year":"1988","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0140","series-title":"Simultaneous determination of methotrexate and sulfasalazine in plasma by HPLC\u2013DAD, LC GC N. AM","first-page":"122","volume":"33","author":"Khera","year":"2015"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00216-012-6302-2","article-title":"Application of quality by design to the development of analytical separation methods","volume":"405","author":"Orlandini","year":"2013","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0150","unstructured":"Food and Drug Administration, Guidance for industry: bioanalytical method validation, http:\/\/www.fda.gov\/cder\/Guidance\/4252fnl.pdf, DOI (2001)."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0155","series-title":"Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products\u2013General Considerations","first-page":"20857","author":"US Food and Drug Administration Centre for Drug Evaluation and Research (FDA)","year":"2003"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0160","series-title":"Guidance for Industry, Q2 (R1): Validation of Analytical Procedures: Text and Methodology","author":"ICH","year":"2005"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0165","first-page":"1190","article-title":"A quality-by-design methodology for rapid LC method development, part I","volume":"26","author":"Swartz","year":"2008","journal-title":"LC GC N. AM."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0170","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1081\/JLC-100100475","article-title":"A review of criteria functions and response surface methodology for the optimization of analytical scale HPLC separations","volume":"23","author":"Klein","year":"2000","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0175","series-title":"Response Surface Methodology: Process and Product Optimization Using Designed Experiments","author":"Myers","year":"2016"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0180","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.chroma.2011.01.059","article-title":"Validation of thin layer and high performance thin layer chromatographic methods","volume":"1218","author":"Renger","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4103\/0250-474X.65023","article-title":"Development and validation of a RP-HPLC method for estimation of montelukast sodium in bulk and in tablet dosage form","volume":"72","author":"Singh","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5958\/0974-360X.2015.00001.3","article-title":"Analytical method development and validation for simultaneous estimation of montelukast and ebastine by HPLC","volume":"8","author":"Baokar","year":"2015","journal-title":"Research J. Pharm. and Tech."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0195","series-title":"Solvent Systems, Thin-Layer Chromatography, Revised and Expanded","author":"Fried","year":"1999"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0200","series-title":"Introduction to Pharmaceutical Chemical Analysis","author":"Hansen","year":"2011"},{"key":"10.1016\/j.jchromb.2019.05.038_bb0205","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-005-0434-6","article-title":"Serum levels and pharmacodynamics of methotrexate and its metabolite 7-hydroxy methotrexate in Japanese patients with rheumatoid arthritis treated with 2-mg capsule of methotrexate three times per week","volume":"15","author":"Shiozawa","year":"2005","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2125.1993.tb04158.x","article-title":"The pharmacokinetics of methotrexate and its 7-hydroxy metabolite in patients with rheumatoid arthritis","volume":"35","author":"Seideman","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0215","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2125.1996.04038.x","article-title":"Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response","volume":"42","author":"Haagsma","year":"1996","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0220","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/03009748709096719","article-title":"The pharmacokinetics of sulphasalazine in young and elderly patients with rheumatoid arthritis","volume":"16","author":"Taggart","year":"1987","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.jchromb.2019.05.038_bb0225","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2125.1996.tb00190.x","article-title":"Hydroxychloroquine relative bioavailability: within subject reproducibility","volume":"41","author":"Tett","year":"1996","journal-title":"Br. J. Clin. Pharmacol."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023218315502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023218315502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:57:36Z","timestamp":1761605856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023218315502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":45,"alternative-id":["S1570023218315502"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.05.038","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Innovative HPTLC method for simultaneous determination of ternary mixture of certain DMARDs in real samples of rheumatoid arthritis patients: an application of quality by design approach","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2019.05.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}